The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation
- PMID: 8491192
- PMCID: PMC413424
- DOI: 10.1002/j.1460-2075.1993.tb05851.x
The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation
Abstract
The v-cbl oncogene is the transforming gene of the murine Cas NS-1 retrovirus which induces pre-B cell lymphomas and myeloid leukaemias. Sequencing of c-cbl has revealed that v-cbl was generated by a large truncation that removed 60% of the C-terminus of the corresponding protein. In this study we prepared antibodies to cbl and found that c-cbl encodes a 120 kDa protein which is localized in the cytoplasm with a cytosolic and cytoskeletal distribution. Immunofluorescence studies show a striking pattern of brightly staining vesicles in mitotic cells similar to that observed with cytokeratin antibodies. In contrast to p120c-cbl, which is exclusively cytoplasmic, the p100gag-v-cbl encoded by Cas NS-1 is localized in both the cytoplasm and the nucleus. This redistribution to the nucleus correlates with the ability of cbl to induce acute transformation. Furthermore the truncated protein encoded by v-cbl can bind DNA, unlike the full-length protein. These results suggest that the C-terminus of cbl is involved in the retention of p120c-cbl in the cytoplasm and the inhibition of DNA binding. The findings also suggest that a truncated protein encoded by c-cbl exists in the nucleus of normal cells.
Similar articles
-
Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.EMBO J. 1994 Oct 3;13(19):4515-23. doi: 10.1002/j.1460-2075.1994.tb06773.x. EMBO J. 1994. PMID: 7925293 Free PMC article.
-
The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.Oncogene. 1991 Apr;6(4):653-7. Oncogene. 1991. PMID: 2030914
-
EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.Oncogene. 1997 May 8;14(18):2239-49. doi: 10.1038/sj.onc.1201193. Oncogene. 1997. PMID: 9174060
-
The Cbl family of signal transduction molecules.Crit Rev Oncog. 1997;8(4):359-79. doi: 10.1615/critrevoncog.v8.i4.50. Crit Rev Oncog. 1997. PMID: 9622055 Review.
-
Cbl: many adaptations to regulate protein tyrosine kinases.Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307. doi: 10.1038/35067100. Nat Rev Mol Cell Biol. 2001. PMID: 11283727 Review.
Cited by
-
Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells.J Exp Med. 1996 Nov 1;184(5):1713-23. doi: 10.1084/jem.184.5.1713. J Exp Med. 1996. PMID: 8920860 Free PMC article.
-
Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes.Biochem J. 1997 Jun 15;324 ( Pt 3)(Pt 3):839-45. doi: 10.1042/bj3240839. Biochem J. 1997. PMID: 9210408 Free PMC article.
-
Arabidopsis COP1 protein specifically interacts in vitro with a cytoskeleton-associated protein, CIP1.Proc Natl Acad Sci U S A. 1995 May 9;92(10):4239-43. doi: 10.1073/pnas.92.10.4239. Proc Natl Acad Sci U S A. 1995. PMID: 7753789 Free PMC article.
-
c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.Cells. 2019 May 23;8(5):498. doi: 10.3390/cells8050498. Cells. 2019. PMID: 31126146 Free PMC article. Review.
-
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.Oncotarget. 2011 Mar;2(3):245-50. doi: 10.18632/oncotarget.233. Oncotarget. 2011. PMID: 21422499 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous